Fabian Muller MD

Dr. Fabian Müller attended medical school at the Albert-Ludwigs University of Freiburg where he also obtained his Dr. med. to understand the epitope binding of B cell receptors better, which he then utilized to target B cells specifically. Dr. Müller started his residency in Hematology and Oncology at the University Hospital of Hamburg Eppendorf, where he continued his work on targeting malignant B cells. The focus of his postdoctoral fellowship with Dr. Ira Pastan, NCI, was to understand resistance to CD22-targeted therapeutics. He continued his work on targeted therapy back at the Friedrich-Alexander University in Erlangen. First with a focus on antibody-directed therapies, later he extended his work to CAR T cells. Today he is heading the CAR T cell unit at the University Clinic of Erlangen and is leading a Max Eder Research group aiming to develop innovative therapeutic approaches to cancer and autoimmune diseases.